

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.40451407 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.81674603 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.74454099 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.73521100 |
| 5 | glutamate secretion (GO:0014047) | 5.70978339 |
| 6 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.65902841 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.64995761 |
| 8 | vocalization behavior (GO:0071625) | 5.63364991 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.52688925 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.40234011 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.25738861 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.18403064 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 5.07578910 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.06390505 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.05006161 |
| 16 | protein localization to synapse (GO:0035418) | 4.97753243 |
| 17 | glutamate receptor signaling pathway (GO:0007215) | 4.83726123 |
| 18 | synaptic transmission, glutamatergic (GO:0035249) | 4.79037925 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.77699588 |
| 20 | nucleobase catabolic process (GO:0046113) | 4.63545488 |
| 21 | exploration behavior (GO:0035640) | 4.62110804 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.55860669 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.52748382 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.51063557 |
| 25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.44405656 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.40871415 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.39571480 |
| 28 | neuron-neuron synaptic transmission (GO:0007270) | 4.38310688 |
| 29 | positive regulation of synapse maturation (GO:0090129) | 4.19923355 |
| 30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.15364866 |
| 31 | presynaptic membrane assembly (GO:0097105) | 4.08979898 |
| 32 | regulation of postsynaptic membrane potential (GO:0060078) | 3.98751581 |
| 33 | layer formation in cerebral cortex (GO:0021819) | 3.95604324 |
| 34 | long-term memory (GO:0007616) | 3.93258541 |
| 35 | neuron recognition (GO:0008038) | 3.92416895 |
| 36 | positive regulation of membrane potential (GO:0045838) | 3.91377203 |
| 37 | presynaptic membrane organization (GO:0097090) | 3.90549830 |
| 38 | cellular potassium ion homeostasis (GO:0030007) | 3.89108507 |
| 39 | cerebellar granule cell differentiation (GO:0021707) | 3.88273670 |
| 40 | cell migration in hindbrain (GO:0021535) | 3.87010661 |
| 41 | dendritic spine morphogenesis (GO:0060997) | 3.86284886 |
| 42 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.86047797 |
| 43 | regulation of synapse structural plasticity (GO:0051823) | 3.83612308 |
| 44 | gamma-aminobutyric acid transport (GO:0015812) | 3.82151547 |
| 45 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.79796832 |
| 46 | proline transport (GO:0015824) | 3.79127596 |
| 47 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.77560963 |
| 48 | postsynaptic membrane organization (GO:0001941) | 3.76483885 |
| 49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.76185630 |
| 50 | regulation of synaptic plasticity (GO:0048167) | 3.72129894 |
| 51 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.68053475 |
| 52 | establishment of mitochondrion localization (GO:0051654) | 3.65295020 |
| 53 | axonal fasciculation (GO:0007413) | 3.64449915 |
| 54 | neurotransmitter transport (GO:0006836) | 3.62557824 |
| 55 | long-term synaptic potentiation (GO:0060291) | 3.61404475 |
| 56 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.60176871 |
| 57 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.58384806 |
| 58 | neuronal ion channel clustering (GO:0045161) | 3.55125558 |
| 59 | regulation of neurotransmitter secretion (GO:0046928) | 3.51537350 |
| 60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.49770020 |
| 61 | synaptic vesicle endocytosis (GO:0048488) | 3.48100864 |
| 62 | neuromuscular synaptic transmission (GO:0007274) | 3.46912814 |
| 63 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.45721316 |
| 64 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.42397838 |
| 65 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.40342049 |
| 66 | regulation of neurotransmitter levels (GO:0001505) | 3.38993497 |
| 67 | behavioral defense response (GO:0002209) | 3.37534946 |
| 68 | behavioral fear response (GO:0001662) | 3.37534946 |
| 69 | sodium ion export (GO:0071436) | 3.35665788 |
| 70 | membrane depolarization (GO:0051899) | 3.35026898 |
| 71 | dendrite morphogenesis (GO:0048813) | 3.34976139 |
| 72 | behavioral response to nicotine (GO:0035095) | 3.33694414 |
| 73 | response to histamine (GO:0034776) | 3.32485957 |
| 74 | innervation (GO:0060384) | 3.31117551 |
| 75 | activation of protein kinase A activity (GO:0034199) | 3.29877474 |
| 76 | transmission of nerve impulse (GO:0019226) | 3.29857306 |
| 77 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.29712114 |
| 78 | regulation of synapse maturation (GO:0090128) | 3.29072069 |
| 79 | negative regulation of dendrite development (GO:2000171) | 3.28571862 |
| 80 | neuromuscular process controlling balance (GO:0050885) | 3.27668676 |
| 81 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.24823353 |
| 82 | regulation of vesicle fusion (GO:0031338) | 3.24089705 |
| 83 | adult walking behavior (GO:0007628) | 3.23227983 |
| 84 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.23106113 |
| 85 | glycosphingolipid biosynthetic process (GO:0006688) | 3.22452988 |
| 86 | membrane depolarization during action potential (GO:0086010) | 3.22101270 |
| 87 | positive regulation of dendritic spine development (GO:0060999) | 3.22083259 |
| 88 | fear response (GO:0042596) | 3.21087860 |
| 89 | membrane hyperpolarization (GO:0060081) | 3.20427075 |
| 90 | neuromuscular process controlling posture (GO:0050884) | 3.17697270 |
| 91 | cell communication by electrical coupling (GO:0010644) | 3.16923465 |
| 92 | regulation of neurotransmitter transport (GO:0051588) | 3.15658315 |
| 93 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.15229426 |
| 94 | learning (GO:0007612) | 3.14441574 |
| 95 | startle response (GO:0001964) | 3.14341218 |
| 96 | synapse organization (GO:0050808) | 3.13979744 |
| 97 | synapse assembly (GO:0007416) | 3.09898446 |
| 98 | auditory behavior (GO:0031223) | 3.08546943 |
| 99 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.07458126 |
| 100 | regulation of synaptic transmission (GO:0050804) | 3.06349876 |
| 101 | synaptic transmission (GO:0007268) | 3.05842818 |
| 102 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.05787044 |
| 103 | regulation of dendritic spine development (GO:0060998) | 3.04683478 |
| 104 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.03838453 |
| 105 | response to auditory stimulus (GO:0010996) | 3.01324944 |
| 106 | positive regulation of synaptic transmission (GO:0050806) | 3.01196361 |
| 107 | neuromuscular process (GO:0050905) | 3.01147676 |
| 108 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.00052823 |
| 109 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.99366600 |
| 110 | positive regulation of neurotransmitter transport (GO:0051590) | 2.99108378 |
| 111 | regulation of respiratory system process (GO:0044065) | 2.98590720 |
| 112 | positive regulation of synapse assembly (GO:0051965) | 2.96799441 |
| 113 | central nervous system neuron axonogenesis (GO:0021955) | 2.96273447 |
| 114 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.95922008 |
| 115 | cochlea development (GO:0090102) | 2.95572298 |
| 116 | mitochondrion transport along microtubule (GO:0047497) | 2.95417614 |
| 117 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.95417614 |
| 118 | mechanosensory behavior (GO:0007638) | 2.95049877 |
| 119 | chemosensory behavior (GO:0007635) | 2.94587292 |
| 120 | establishment of synaptic vesicle localization (GO:0097480) | 2.90996453 |
| 121 | synaptic vesicle transport (GO:0048489) | 2.90996453 |
| 122 | serotonin metabolic process (GO:0042428) | 2.89826988 |
| 123 | neuronal action potential (GO:0019228) | 2.88949409 |
| 124 | axon ensheathment in central nervous system (GO:0032291) | 2.88118768 |
| 125 | central nervous system myelination (GO:0022010) | 2.88118768 |
| 126 | negative regulation of axonogenesis (GO:0050771) | 2.85541752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.30986437 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.08876460 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14777332 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.09002035 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05572877 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69531546 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69298275 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69298275 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.61909513 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.57093630 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57076769 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47730643 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45980579 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.45338123 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42946587 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42898570 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.41181082 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32019681 |
| 19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.23934881 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.22590009 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.17922683 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16924600 |
| 23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16309830 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15890836 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.07900699 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.01154038 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.90314779 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88823659 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88157676 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82384792 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.82318705 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.78887603 |
| 33 | * TAF15_26573619_Chip-Seq_HEK293_Human | 1.76684767 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76214536 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64577741 |
| 36 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64477236 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57536641 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.54042431 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52009238 |
| 40 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.48877916 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42759715 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.40267928 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38699649 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38522967 |
| 45 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38174511 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36489875 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35629804 |
| 48 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35300482 |
| 49 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.32374453 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30628048 |
| 51 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30204226 |
| 52 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.27391703 |
| 53 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.27315278 |
| 54 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27115067 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27030981 |
| 56 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25952423 |
| 57 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25218048 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22942848 |
| 59 | * AR_19668381_ChIP-Seq_PC3_Human | 1.21974558 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21957301 |
| 61 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.20061739 |
| 62 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19062494 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18768883 |
| 64 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18750582 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17923764 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17002083 |
| 67 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15001444 |
| 68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14047255 |
| 69 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.13865097 |
| 70 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13272294 |
| 71 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.10989828 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10249205 |
| 73 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09057252 |
| 74 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08926618 |
| 75 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08722765 |
| 76 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08668541 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08216428 |
| 78 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07921237 |
| 79 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.07812574 |
| 80 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.07430833 |
| 81 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07252146 |
| 82 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06695793 |
| 83 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06695793 |
| 84 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06394993 |
| 85 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.06332599 |
| 86 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.05716571 |
| 87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05197803 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03871443 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02148714 |
| 90 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01755707 |
| 91 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01409179 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01031278 |
| 93 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.98896802 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98587710 |
| 95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98587710 |
| 96 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97130045 |
| 97 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.96458835 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96445223 |
| 99 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96053792 |
| 100 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95793607 |
| 101 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94838593 |
| 102 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94737046 |
| 103 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94708086 |
| 104 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94292547 |
| 105 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.93750109 |
| 106 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93691558 |
| 107 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93329367 |
| 108 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.92844180 |
| 109 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92327948 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92096823 |
| 111 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91689489 |
| 112 | * JUN_21703547_ChIP-Seq_K562_Human | 0.91208485 |
| 113 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90925075 |
| 114 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90416635 |
| 115 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.90320185 |
| 116 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.89051282 |
| 117 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88626911 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88590722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.85905154 |
| 2 | MP0003880_abnormal_central_pattern | 5.15708582 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.31160874 |
| 4 | MP0004270_analgesia | 3.81780516 |
| 5 | MP0009745_abnormal_behavioral_response | 3.51272318 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.45633161 |
| 7 | MP0002064_seizures | 3.28725490 |
| 8 | MP0009046_muscle_twitch | 3.23832046 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.19302571 |
| 10 | * MP0002572_abnormal_emotion/affect_behav | 2.93235111 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.90510086 |
| 12 | MP0002272_abnormal_nervous_system | 2.68560663 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.65046550 |
| 14 | MP0001486_abnormal_startle_reflex | 2.60511816 |
| 15 | MP0002736_abnormal_nociception_after | 2.56396773 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.50125166 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.32779065 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.27557943 |
| 19 | MP0002067_abnormal_sensory_capabilities | 2.12030161 |
| 20 | MP0002733_abnormal_thermal_nociception | 1.99461065 |
| 21 | MP0008569_lethality_at_weaning | 1.96679333 |
| 22 | MP0001970_abnormal_pain_threshold | 1.95966718 |
| 23 | MP0002184_abnormal_innervation | 1.95182049 |
| 24 | MP0000778_abnormal_nervous_system | 1.94724969 |
| 25 | MP0002822_catalepsy | 1.82705445 |
| 26 | MP0003329_amyloid_beta_deposits | 1.82549768 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.82316232 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.79847318 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.78573954 |
| 30 | MP0004924_abnormal_behavior | 1.77415376 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.77415376 |
| 32 | MP0003879_abnormal_hair_cell | 1.77394081 |
| 33 | MP0004858_abnormal_nervous_system | 1.75440204 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.66207276 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.60810745 |
| 36 | MP0000955_abnormal_spinal_cord | 1.59261566 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.57753806 |
| 38 | MP0003121_genomic_imprinting | 1.56890914 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.47966088 |
| 40 | MP0003787_abnormal_imprinting | 1.45673821 |
| 41 | * MP0002066_abnormal_motor_capabilities/c | 1.44664723 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.44004621 |
| 43 | MP0001984_abnormal_olfaction | 1.42797873 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.40866289 |
| 45 | MP0004885_abnormal_endolymph | 1.40455379 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.37783182 |
| 47 | MP0001188_hyperpigmentation | 1.31418805 |
| 48 | * MP0003633_abnormal_nervous_system | 1.31038365 |
| 49 | MP0008877_abnormal_DNA_methylation | 1.29339161 |
| 50 | MP0002102_abnormal_ear_morphology | 1.29230944 |
| 51 | MP0004142_abnormal_muscle_tone | 1.28968501 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.26707584 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.18164020 |
| 54 | * MP0003631_nervous_system_phenotype | 1.15090013 |
| 55 | MP0001905_abnormal_dopamine_level | 1.14640963 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.14633361 |
| 57 | MP0002152_abnormal_brain_morphology | 1.13779461 |
| 58 | MP0003122_maternal_imprinting | 1.13060249 |
| 59 | MP0001529_abnormal_vocalization | 1.10071812 |
| 60 | MP0008872_abnormal_physiological_respon | 1.03802432 |
| 61 | MP0004742_abnormal_vestibular_system | 1.02873174 |
| 62 | MP0000751_myopathy | 0.98767079 |
| 63 | MP0002751_abnormal_autonomic_nervous | 0.98500232 |
| 64 | MP0010386_abnormal_urinary_bladder | 0.94406674 |
| 65 | MP0002069_abnormal_eating/drinking_beha | 0.93779002 |
| 66 | MP0002229_neurodegeneration | 0.93465582 |
| 67 | MP0000049_abnormal_middle_ear | 0.91317969 |
| 68 | MP0008874_decreased_physiological_sensi | 0.90315968 |
| 69 | MP0004133_heterotaxia | 0.89194816 |
| 70 | MP0003632_abnormal_nervous_system | 0.88343183 |
| 71 | MP0001963_abnormal_hearing_physiology | 0.88083386 |
| 72 | MP0003123_paternal_imprinting | 0.87645243 |
| 73 | MP0004085_abnormal_heartbeat | 0.82093560 |
| 74 | MP0005551_abnormal_eye_electrophysiolog | 0.81582354 |
| 75 | MP0003634_abnormal_glial_cell | 0.78653539 |
| 76 | MP0000604_amyloidosis | 0.78455621 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.77822603 |
| 78 | MP0008789_abnormal_olfactory_epithelium | 0.77768917 |
| 79 | MP0003119_abnormal_digestive_system | 0.77597834 |
| 80 | MP0003690_abnormal_glial_cell | 0.76800704 |
| 81 | MP0001177_atelectasis | 0.76608084 |
| 82 | MP0005409_darkened_coat_color | 0.75761772 |
| 83 | MP0003938_abnormal_ear_development | 0.75066489 |
| 84 | MP0002752_abnormal_somatic_nervous | 0.75009064 |
| 85 | MP0000920_abnormal_myelination | 0.74470849 |
| 86 | MP0001485_abnormal_pinna_reflex | 0.72500780 |
| 87 | MP0004215_abnormal_myocardial_fiber | 0.72386292 |
| 88 | MP0005253_abnormal_eye_physiology | 0.72271859 |
| 89 | MP0005171_absent_coat_pigmentation | 0.70662830 |
| 90 | MP0005394_taste/olfaction_phenotype | 0.70208263 |
| 91 | MP0005499_abnormal_olfactory_system | 0.70208263 |
| 92 | MP0005535_abnormal_body_temperature | 0.69876593 |
| 93 | MP0004147_increased_porphyrin_level | 0.69661236 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.69519815 |
| 95 | MP0004484_altered_response_of | 0.69343140 |
| 96 | MP0003075_altered_response_to | 0.68168776 |
| 97 | MP0003890_abnormal_embryonic-extraembry | 0.65566072 |
| 98 | MP0000013_abnormal_adipose_tissue | 0.63831806 |
| 99 | MP0004510_myositis | 0.63154086 |
| 100 | MP0001664_abnormal_digestion | 0.62750341 |
| 101 | MP0004233_abnormal_muscle_weight | 0.62338885 |
| 102 | MP0008961_abnormal_basal_metabolism | 0.61416843 |
| 103 | MP0005195_abnormal_posterior_eye | 0.61399072 |
| 104 | MP0003861_abnormal_nervous_system | 0.61127639 |
| 105 | MP0005367_renal/urinary_system_phenotyp | 0.60867821 |
| 106 | MP0000516_abnormal_urinary_system | 0.60867821 |
| 107 | MP0002081_perinatal_lethality | 0.60648537 |
| 108 | MP0002234_abnormal_pharynx_morphology | 0.60303852 |
| 109 | MP0003137_abnormal_impulse_conducting | 0.59497741 |
| 110 | MP0002160_abnormal_reproductive_system | 0.59050683 |
| 111 | * MP0010769_abnormal_survival | 0.58191819 |
| 112 | * MP0002082_postnatal_lethality | 0.56865852 |
| 113 | * MP0010770_preweaning_lethality | 0.56865852 |
| 114 | MP0001943_abnormal_respiration | 0.56307674 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.54762289 |
| 116 | * MP0010768_mortality/aging | 0.54699321 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.51955874 |
| 118 | MP0005187_abnormal_penis_morphology | 0.51778756 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.51005305 |
| 120 | MP0000026_abnormal_inner_ear | 0.50244519 |
| 121 | MP0003283_abnormal_digestive_organ | 0.50011248 |
| 122 | * MP0003956_abnormal_body_size | 0.49888605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.29664697 |
| 2 | Myokymia (HP:0002411) | 6.44943387 |
| 3 | Focal seizures (HP:0007359) | 6.15220978 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.59225613 |
| 5 | Visual hallucinations (HP:0002367) | 5.13227151 |
| 6 | Atonic seizures (HP:0010819) | 4.94419135 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.87720995 |
| 8 | Febrile seizures (HP:0002373) | 4.78768518 |
| 9 | Absence seizures (HP:0002121) | 4.50896273 |
| 10 | Hyperventilation (HP:0002883) | 4.26949937 |
| 11 | Action tremor (HP:0002345) | 4.21294812 |
| 12 | Dialeptic seizures (HP:0011146) | 4.15164893 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 4.04074498 |
| 14 | Broad-based gait (HP:0002136) | 4.01758867 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.68161319 |
| 16 | Poor eye contact (HP:0000817) | 3.67042588 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.35713296 |
| 18 | Abnormal social behavior (HP:0012433) | 3.24848599 |
| 19 | Impaired social interactions (HP:0000735) | 3.24848599 |
| 20 | Excessive salivation (HP:0003781) | 3.21073319 |
| 21 | Drooling (HP:0002307) | 3.21073319 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.19962276 |
| 23 | Amblyopia (HP:0000646) | 3.17591954 |
| 24 | Truncal ataxia (HP:0002078) | 3.15759491 |
| 25 | Genetic anticipation (HP:0003743) | 3.14152633 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.13050623 |
| 27 | Dysmetria (HP:0001310) | 3.08604125 |
| 28 | Depression (HP:0000716) | 3.05972727 |
| 29 | Mutism (HP:0002300) | 2.96894100 |
| 30 | Postural instability (HP:0002172) | 2.96525820 |
| 31 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.95350531 |
| 32 | Ankle clonus (HP:0011448) | 2.95276466 |
| 33 | Abnormal eating behavior (HP:0100738) | 2.94900349 |
| 34 | Gait imbalance (HP:0002141) | 2.91285209 |
| 35 | Impaired smooth pursuit (HP:0007772) | 2.89702662 |
| 36 | Absent speech (HP:0001344) | 2.86222570 |
| 37 | Scanning speech (HP:0002168) | 2.80434345 |
| 38 | Epileptiform EEG discharges (HP:0011182) | 2.77714894 |
| 39 | Anxiety (HP:0000739) | 2.77374521 |
| 40 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.66906446 |
| 41 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.66906446 |
| 42 | Hemiparesis (HP:0001269) | 2.64793579 |
| 43 | Retinal dysplasia (HP:0007973) | 2.62557384 |
| 44 | Abnormality of binocular vision (HP:0011514) | 2.62009266 |
| 45 | Diplopia (HP:0000651) | 2.62009266 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.61351477 |
| 47 | Lissencephaly (HP:0001339) | 2.58477801 |
| 48 | Stereotypic behavior (HP:0000733) | 2.58235498 |
| 49 | Dysmetric saccades (HP:0000641) | 2.57389695 |
| 50 | Papilledema (HP:0001085) | 2.54895251 |
| 51 | Inability to walk (HP:0002540) | 2.54841542 |
| 52 | Urinary urgency (HP:0000012) | 2.54558250 |
| 53 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.53567801 |
| 54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.53026412 |
| 55 | Progressive inability to walk (HP:0002505) | 2.50334852 |
| 56 | Bradykinesia (HP:0002067) | 2.47390230 |
| 57 | Status epilepticus (HP:0002133) | 2.43897584 |
| 58 | Hemiplegia (HP:0002301) | 2.43601827 |
| 59 | Spastic gait (HP:0002064) | 2.43000864 |
| 60 | Spastic tetraplegia (HP:0002510) | 2.39790159 |
| 61 | Cerebral inclusion bodies (HP:0100314) | 2.37475589 |
| 62 | Medial flaring of the eyebrow (HP:0010747) | 2.35532054 |
| 63 | Intention tremor (HP:0002080) | 2.35025641 |
| 64 | Hypsarrhythmia (HP:0002521) | 2.34205841 |
| 65 | Torticollis (HP:0000473) | 2.34073633 |
| 66 | Fetal akinesia sequence (HP:0001989) | 2.33362441 |
| 67 | Congenital primary aphakia (HP:0007707) | 2.32543226 |
| 68 | Cortical dysplasia (HP:0002539) | 2.31734956 |
| 69 | Termporal pattern (HP:0011008) | 2.31217886 |
| 70 | Insidious onset (HP:0003587) | 2.31217886 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.30564420 |
| 72 | Polyphagia (HP:0002591) | 2.30106120 |
| 73 | Blue irides (HP:0000635) | 2.29915552 |
| 74 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.29357161 |
| 75 | Abnormality of the corticospinal tract (HP:0002492) | 2.28598052 |
| 76 | Pachygyria (HP:0001302) | 2.25750802 |
| 77 | Protruding tongue (HP:0010808) | 2.25067188 |
| 78 | Focal dystonia (HP:0004373) | 2.22891600 |
| 79 | Impaired vibratory sensation (HP:0002495) | 2.21861616 |
| 80 | Pheochromocytoma (HP:0002666) | 2.21663428 |
| 81 | Limb dystonia (HP:0002451) | 2.20321414 |
| 82 | Peripheral hypomyelination (HP:0007182) | 2.20235904 |
| 83 | Nephrogenic diabetes insipidus (HP:0009806) | 2.19021320 |
| 84 | Hypoplasia of the corpus callosum (HP:0002079) | 2.16530158 |
| 85 | Abnormality of salivation (HP:0100755) | 2.11954907 |
| 86 | Generalized myoclonic seizures (HP:0002123) | 2.10548938 |
| 87 | Megalencephaly (HP:0001355) | 2.09848562 |
| 88 | Amyotrophic lateral sclerosis (HP:0007354) | 2.08937067 |
| 89 | Abnormality of the labia minora (HP:0012880) | 2.05371693 |
| 90 | Esotropia (HP:0000565) | 2.05241815 |
| 91 | Hypoventilation (HP:0002791) | 2.03751006 |
| 92 | Agitation (HP:0000713) | 2.03350489 |
| 93 | Inappropriate behavior (HP:0000719) | 2.02664407 |
| 94 | Vaginal atresia (HP:0000148) | 2.02369242 |
| 95 | Hepatoblastoma (HP:0002884) | 2.00783964 |
| 96 | Genital tract atresia (HP:0001827) | 2.00074682 |
| 97 | Incomplete penetrance (HP:0003829) | 1.99962948 |
| 98 | Poor suck (HP:0002033) | 1.97805174 |
| 99 | Lower limb muscle weakness (HP:0007340) | 1.97352978 |
| 100 | Gait ataxia (HP:0002066) | 1.96442742 |
| 101 | Split foot (HP:0001839) | 1.95331873 |
| 102 | Sleep apnea (HP:0010535) | 1.95236214 |
| 103 | Intellectual disability, severe (HP:0010864) | 1.94265712 |
| 104 | Paraplegia (HP:0010550) | 1.92489922 |
| 105 | Craniofacial dystonia (HP:0012179) | 1.89616332 |
| 106 | True hermaphroditism (HP:0010459) | 1.89030243 |
| 107 | Neuroendocrine neoplasm (HP:0100634) | 1.88985021 |
| 108 | Ventricular fibrillation (HP:0001663) | 1.86467011 |
| 109 | Exotropia (HP:0000577) | 1.81858459 |
| 110 | Molar tooth sign on MRI (HP:0002419) | 1.81189260 |
| 111 | Abnormality of midbrain morphology (HP:0002418) | 1.81189260 |
| 112 | Type II lissencephaly (HP:0007260) | 1.80345465 |
| 113 | Pointed chin (HP:0000307) | 1.79964332 |
| 114 | Neuronal loss in central nervous system (HP:0002529) | 1.79878355 |
| 115 | Oligodactyly (hands) (HP:0001180) | 1.79649782 |
| 116 | Obstructive sleep apnea (HP:0002870) | 1.78372022 |
| 117 | Psychosis (HP:0000709) | 1.77941194 |
| 118 | Annular pancreas (HP:0001734) | 1.77887373 |
| 119 | Ulnar claw (HP:0001178) | 1.77466209 |
| 120 | Aqueductal stenosis (HP:0002410) | 1.77194482 |
| 121 | Nephronophthisis (HP:0000090) | 1.76876800 |
| 122 | Pancreatic fibrosis (HP:0100732) | 1.76468572 |
| 123 | Clonus (HP:0002169) | 1.75917741 |
| 124 | Abnormality of saccadic eye movements (HP:0000570) | 1.74219902 |
| 125 | Rigidity (HP:0002063) | 1.73590994 |
| 126 | Specific learning disability (HP:0001328) | 1.72349779 |
| 127 | Widely spaced teeth (HP:0000687) | 1.72037730 |
| 128 | Delusions (HP:0000746) | 1.70032483 |
| 129 | Akinesia (HP:0002304) | 1.69670507 |
| 130 | Lower limb asymmetry (HP:0100559) | 1.69627931 |
| 131 | Open mouth (HP:0000194) | 1.68772783 |
| 132 | Hypoplasia of the brainstem (HP:0002365) | 1.68318641 |
| 133 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.68318641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.60069345 |
| 2 | EPHA4 | 4.12226174 |
| 3 | MAP3K9 | 3.35114477 |
| 4 | MARK1 | 3.33528912 |
| 5 | MAP3K4 | 3.20425734 |
| 6 | CASK | 2.96397170 |
| 7 | MAP2K7 | 2.76617279 |
| 8 | MINK1 | 2.59805720 |
| 9 | DAPK2 | 2.57802748 |
| 10 | PAK6 | 2.25032350 |
| 11 | MAP3K12 | 2.17902566 |
| 12 | NTRK2 | 2.07396732 |
| 13 | MAP2K4 | 2.03433112 |
| 14 | CDK19 | 2.01096194 |
| 15 | DAPK1 | 1.88273465 |
| 16 | DYRK2 | 1.83145470 |
| 17 | RIPK4 | 1.82709465 |
| 18 | KSR1 | 1.77539461 |
| 19 | KSR2 | 1.75908883 |
| 20 | PLK2 | 1.73533720 |
| 21 | CAMKK1 | 1.68457702 |
| 22 | TNIK | 1.59353032 |
| 23 | MAPK13 | 1.58989677 |
| 24 | FRK | 1.58190923 |
| 25 | PRKD3 | 1.57532820 |
| 26 | PNCK | 1.54252055 |
| 27 | CDK5 | 1.52059007 |
| 28 | MAP4K2 | 1.49958076 |
| 29 | EPHA3 | 1.48729127 |
| 30 | PRPF4B | 1.48606486 |
| 31 | NTRK1 | 1.46662142 |
| 32 | CSNK1G3 | 1.45958847 |
| 33 | TRIM28 | 1.42909482 |
| 34 | CSNK1A1L | 1.35786887 |
| 35 | PRKCG | 1.33373164 |
| 36 | CAMKK2 | 1.30045805 |
| 37 | SIK2 | 1.23703451 |
| 38 | STK38 | 1.23278120 |
| 39 | GRK5 | 1.19841022 |
| 40 | CSNK1G1 | 1.13509118 |
| 41 | CCNB1 | 1.11177190 |
| 42 | CAMK2A | 1.10003114 |
| 43 | OXSR1 | 1.04712471 |
| 44 | FES | 1.01399696 |
| 45 | CAMK1 | 0.99648488 |
| 46 | DYRK3 | 0.99298503 |
| 47 | UHMK1 | 0.98517910 |
| 48 | SGK494 | 0.98115888 |
| 49 | SGK223 | 0.98115888 |
| 50 | CAMK2B | 0.95276601 |
| 51 | SGK2 | 0.95026209 |
| 52 | CDK18 | 0.94615890 |
| 53 | TYRO3 | 0.93488511 |
| 54 | LATS2 | 0.91411418 |
| 55 | MAP3K2 | 0.91021362 |
| 56 | CDK15 | 0.90244749 |
| 57 | ARAF | 0.90225657 |
| 58 | PHKG2 | 0.89482379 |
| 59 | PHKG1 | 0.89482379 |
| 60 | SIK3 | 0.86284672 |
| 61 | CDK14 | 0.85370418 |
| 62 | MAP3K13 | 0.85238510 |
| 63 | PKN1 | 0.82810523 |
| 64 | STK11 | 0.82395601 |
| 65 | PTK2B | 0.78999249 |
| 66 | CDK11A | 0.78116983 |
| 67 | RAF1 | 0.76766690 |
| 68 | CAMK1G | 0.76384946 |
| 69 | ERBB3 | 0.76249702 |
| 70 | RET | 0.75493127 |
| 71 | SGK1 | 0.75267198 |
| 72 | SGK3 | 0.75013007 |
| 73 | CSNK1G2 | 0.74116345 |
| 74 | TAOK1 | 0.71564253 |
| 75 | PRKCH | 0.71362258 |
| 76 | PAK3 | 0.71323815 |
| 77 | DYRK1A | 0.71017146 |
| 78 | BMPR2 | 0.68218973 |
| 79 | MARK2 | 0.65618138 |
| 80 | AKT3 | 0.64033028 |
| 81 | PDK1 | 0.59675564 |
| 82 | CSNK1A1 | 0.59379642 |
| 83 | ADRBK2 | 0.58243853 |
| 84 | PINK1 | 0.56543743 |
| 85 | DYRK1B | 0.55291773 |
| 86 | PDPK1 | 0.54777179 |
| 87 | LMTK2 | 0.53969977 |
| 88 | FGFR2 | 0.53304987 |
| 89 | CSNK1D | 0.52674872 |
| 90 | GRK1 | 0.52562667 |
| 91 | PRKCE | 0.52405010 |
| 92 | ALK | 0.52376531 |
| 93 | CAMK2G | 0.49227842 |
| 94 | WNK3 | 0.48997673 |
| 95 | CAMK4 | 0.48984354 |
| 96 | PRKCZ | 0.48865915 |
| 97 | NEK6 | 0.47325617 |
| 98 | CAMK2D | 0.47319673 |
| 99 | RPS6KA3 | 0.46453630 |
| 100 | MAP3K7 | 0.45157103 |
| 101 | MAP3K1 | 0.45108567 |
| 102 | RPS6KA4 | 0.45099282 |
| 103 | PRKACA | 0.44464559 |
| 104 | BCR | 0.44415070 |
| 105 | DMPK | 0.42832962 |
| 106 | PRKAA1 | 0.41799403 |
| 107 | FYN | 0.41761969 |
| 108 | WNK1 | 0.40623979 |
| 109 | FGR | 0.40247447 |
| 110 | MAPK12 | 0.39277885 |
| 111 | TNK2 | 0.39125046 |
| 112 | CSNK1E | 0.37563644 |
| 113 | MAPK8 | 0.37388485 |
| 114 | MAPK10 | 0.37153100 |
| 115 | FER | 0.36667820 |
| 116 | CDC42BPA | 0.36470000 |
| 117 | MAP2K1 | 0.36378812 |
| 118 | MAP3K6 | 0.35708974 |
| 119 | ERBB2 | 0.35103418 |
| 120 | DAPK3 | 0.34683063 |
| 121 | ROCK2 | 0.33687171 |
| 122 | PRKCB | 0.33458870 |
| 123 | GSK3B | 0.32488502 |
| 124 | MAPK9 | 0.30584651 |
| 125 | PRKCA | 0.30064013 |
| 126 | MAPK15 | 0.30001970 |
| 127 | PRKACB | 0.28916978 |
| 128 | PRKG1 | 0.28671259 |
| 129 | LIMK1 | 0.27939876 |
| 130 | INSRR | 0.26647524 |
| 131 | MAPKAPK5 | 0.26203818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.22653579 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.35594074 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.88295596 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.83999908 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.81353150 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.74408419 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.67622598 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.58593005 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.47876476 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.46749933 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.28092981 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16823805 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14483842 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.03244295 |
| 15 | Long-term depression_Homo sapiens_hsa04730 | 1.87109021 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87062010 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.86283897 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.84594546 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.83638279 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.67749305 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67638815 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.67351089 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.65362626 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64333931 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.61289256 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.48628976 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41093253 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.36813978 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.32591839 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31544867 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.30550044 |
| 32 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.29626698 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.27594899 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26765310 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23686414 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21728211 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12863154 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11889608 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11395120 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08354089 |
| 41 | Glioma_Homo sapiens_hsa05214 | 1.08014232 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05108833 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.00993331 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97986868 |
| 45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.93736988 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93329464 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.91253683 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88550107 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87880881 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86741247 |
| 51 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86472444 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78874819 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78347198 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73708051 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73656796 |
| 56 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73595001 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73261946 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71573265 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70277195 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.69140704 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67008069 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66247198 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65192616 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63015505 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60947250 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.60248780 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.60012936 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58946852 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57587126 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55582995 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54036943 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53904124 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53446173 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51913205 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51869035 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50001046 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49702674 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48935714 |
| 79 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48653616 |
| 80 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47599211 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47256182 |
| 82 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46536197 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46481907 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45686360 |
| 85 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45343104 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45317269 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44609177 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44547085 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44273467 |
| 90 | Bile secretion_Homo sapiens_hsa04976 | 0.43486534 |
| 91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43097160 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42812489 |
| 93 | Alcoholism_Homo sapiens_hsa05034 | 0.42711610 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42275682 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41322541 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39845477 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.38995156 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38971062 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38910277 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.38058897 |
| 101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37626847 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.36804879 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35632670 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34790967 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34459307 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33733126 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33250528 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33018740 |
| 109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31300302 |
| 110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31220922 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31008186 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30867418 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30756054 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30422998 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30402290 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29203229 |
| 117 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26762832 |
| 118 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26035698 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.26009835 |
| 120 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.25714809 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24992845 |
| 122 | Tight junction_Homo sapiens_hsa04530 | 0.21814152 |
| 123 | Huntingtons disease_Homo sapiens_hsa05016 | 0.21211730 |

